Hims & Hers gains on partnership with Eli Lilly

Hims & Hers Health (HIMS) stock rises as the company inks a partnership to sell Eli Lilly's (LLY) weight-loss drugs, Zepbound and Foundayo. Read more here.

1 sources · 1 articles · updated 2026-11-06 12:35 UTC · business

Coverage